1 / 20

Genomic Signal Analysis of HIV-1 Clade F Protease and Reverse Transcriptase Variability

Genomic Signal Analysis of HIV-1 Clade F Protease and Reverse Transcriptase Variability. XVI International AIDS Conference Toronto Canada • August 13 - 18 août 2006 XVI Congrès international sur le sida Late Breaker Track A Thursday, 17 August 2006, Session Time: 16:15 - 17:45

lawrence-rich
Télécharger la présentation

Genomic Signal Analysis of HIV-1 Clade F Protease and Reverse Transcriptase Variability

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Genomic Signal Analysis of HIV-1 Clade F Protease and Reverse Transcriptase Variability XVI International AIDS Conference Toronto Canada • August 13 - 18 août 2006 XVI Congrès international sur le sida Late Breaker Track A Thursday, 17 August 2006, Session Time: 16:15 - 17:45 Room: SR 7, Abstract number: THLB0308 Paul Dan CRISTEA, Rodica Aurora TUDUCE Bio-Medical Engineering Center, “Politehnica” University of Bucharest Spl. Independentei 313, 060042 Bucharest, Romania {pcristea, trodica}@dsp.pub.ro

  2. 5' end H CH3 3' end O O H P O H H N N O T O- N N CH2 A N O H N CH2 CH2 CH2 O N O H O- O- O- O O O O H O O O P P P P H O N H N O O H O O- C G N CH2 H N O N N O N O O H N O H 5' to 3' direction CH3 O O 5' to 3' direction H H P N H H O N O O- T N CH2 A N O N CH2 N H N O- O O H P H O O O P O N H O N H O H O O O- C G CH2 N N H N O N N H O N 3' end H 5' end DNA structure

  3. Conversion of symbolic sequences Nucleotide classes G (guanine) A (adenine) R (purines) K (keto) M (amino) Y (pyrimidines) C (cytosine) . T(thymine) S (strong link) W (weak link)

  4. Mapping of nucleotide classes ( IUPAC symbols )

  5. Cumulated and Unwrapped Phases Cumulated phase - sum of the phases from the first to the current element in a sequence. Unwrapped phase- corrected phase of elements in a sequence, so that the absolute value of the difference between the phase of an element in the sequence and the phase of its preceding element is kept smaller than . Positive transitions: AG, GC, CT, TA Negative transitions: AT, TC, CG, GA Neutral transitions: AA, TT, CC, GG, AC, CA, GT, TG

  6. Homo sapienschr 1, all contigs (phase 3, length 228507674 bp)

  7. EscherichiacoliK12

  8. Human immunodeficiency virus 1 NC 001802

  9. Variations of nucleotides (SNPs) tend to compensate each other. A genomic sequence satisfies more structural restrictions than a "plain text", and resembles more to a "poem", which obeys rules of symmetry giving "rhythm" and "rhyme". The recurrence of patterned structures in nucleotide sequences results in mathematical rules satisfied by genomic signals. Study of HIV Variability

  10. In HIV virus only SNPs type mutations are significant, while cross-over type mutations do not occur. SNPs resulting in drug resistance are located in well defined positions in each gene. Samples were classified in three groups from the point of view of their resistance to current antiretroviral compounds: sensitive (S), resistant (R) and multiresistant (M).

  11. Sequences from Clade F HIV-1 isolates from Romanian patients have been genotyped in the laboratory of the National Institute of Infectious Diseases “Prof. Dr. Matei Bals” of Bucharest. The analyzed segment has 1302 base pairs, aligning with the standard sequence of HIV-1 (accession NC001802 in GenBank) over the interval 1799..2430 bp. This segment is currently used for the standard identification and assessment of HIV-1 strains, and comprises the protease (PR) gene and two thirds of the reverse transcriptase (RT) gene.

  12. Unwrapped phase for PR of three multiple drug resistant isolates of HIV-1, subtype F

  13. Variations of the unwrapped phase signals with respect to the MaxFlat reference

  14. Digital derivatives of the variations with respect to the maximum flat reference

  15. Protease inhibitors HIV mutations in patients starting the antiretroviral therapy occur primarily at the level of the final enzyme product, preventing the blocking of the PR catalytic site under the effect of the drug. In multiple drug resistant patients, significant changes also occur at the level of PR gene RNA secondary structure. The changes consists in the replacement of large loops and bulges by smaller closed-loop structures. This result reveals a more complex mechanism of both drug action and drug-resistance development process.

  16. PR_S_518_2003 PR_S_800_2003 PR_S_623_2003 PR_R_398_2003 PR_R_435_2003 PR_R_464_2003 RNA secondary structure

  17. PR_M_382_2003 PR_M_519_2003 PR_M_505_2003

  18. Phylogenetic Neighbor- Joining Tree of 28 instances of multiresistant HIV-1, Subtype F built using the PR genomic signal of length 297 bp

  19. Acknowledgment The data referring to the F subtype HIV strains isolated in Romaniahave been provided by Dr. Dan Otelea from the National Institute of Infectious Diseases “Prof.Dr.Matei Bals”. The project has been partially supported by grants from the Ministry of Education and Research of Romania in the framework of the RELANSIN and CNCSIS Programmes.

More Related